Single-Cell RNA-seq Reveals Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 Expression in TROP2+ Liver Progenitor Cells: Implications in Coronavirus Disease 2019-Associated Liver Dysfunction
Open accessPublished version of a preprint
The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.
Abstract
The recent coronavirus disease 2019 (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2. COVID-19 was first reported in China (December 2019) and is now prevalent across the globe. Entry of severe acute respiratory syndrome coronavirus 2 into mammalian cells requires the binding of viral Spike (S) proteins to the angiotensin-converting enzyme 2 receptor. Once entered, the S protein is primed by a specialized serine protease, transmembrane serine protease 2 in the host cell. Importantly, besides the respiratory symptoms that are consistent with other common respiratory virus infections when patients become viremic, a significant number of COVID-19 patients also develop liver comorbidities. We explored whether a specific target cell-type in the mammalian liver could be implicated in disease pathophysiology other than the general deleterious response to cytokine storms. Here, we used single-cell RNA-seq to survey the human liver and identified potentially implicated liver cell-type for viral ingress. We analyzed ~300,000 single cells across five different (i.e., human fetal, healthy, cirrhotic, tumor, and adjacent normal) liver tissue types. This study reports on the co-expression of angiotensin-converting enzyme 2 and transmembrane serine protease 2 in a TROP2 + liver progenitor population. Importantly, we detected enrichment of this cell population in the cirrhotic liver when compared with tumor tissue. These results indicated that in COVID-19-associated liver dysfunction and cell death, a viral infection of TROP2 + progenitors in the liver might significantly impair liver regeneration in patients with liver cirrhosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The proximal origin of SARS-CoV-2
Andersen, K. G., Rambaut, A., Lipkin, W. I., Holmes, E. C., & Garry, R. F. (2020) · Nature Medicine · doi:10.1038/s41591-020-0820-9 · Cited by 5,081
Ziegler, C. G. K., Allon, S. J., Nyquist, S. K., Mbano, I. M., Miao, V. N., Tzouanas, C. N., Cao, Y., Yousif, A. S., Bals, J., Hauser, B. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.035 · Cited by 2,284
Resolving the fibrotic niche of human liver cirrhosis at single-cell level
Ramachandran, P., Dobie, R., Wilson-Kanamori, J. R., Dora, E. F., Henderson, B. E. P., Luu, N. T., Portman, J. R., Matchett, K. P., Brice, M., Marwick, J. A., et al. (2019) · Nature · doi:10.1038/s41586-019-1631-3 · Cited by 1,784 · cited 1×
“Furthermore, we integrated these data with healthy (19) and cirrhotic (20) human liver scRNA-seq data.”
MethodSingle cell RNA sequencing of human liver reveals distinct intrahepatic macrophage populations
MacParland, S. A., Liu, J. C., Ma, X.-Z., Innes, B. T., Bartczak, A. M., Gage, B. K., Manuel, J., Khuu, N., Echeverri, J., Linares, I., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06318-7 · Cited by 1,552 · cited 1×
“Furthermore, we integrated these data with healthy (19) and cirrhotic (20) human liver scRNA-seq data.”
MethodA human liver cell atlas reveals heterogeneity and epithelial progenitors
Aizarani, N., Saviano, A., Sagar, Mailly, L., Durand, S., Herman, J. S., Pessaux, P., Baumert, T. F., & Grün, D. (2019) · Nature · doi:10.1038/s41586-019-1373-2 · Cited by 1,147 · cited 4×
“TROP2 expression is known to mark the fate of liver epithelial progenitors, where lower TROP2 expression is linked with hepatocyte fate and TROP2high cells with cholangiocyte fate (21).”
BackgroundInfluentialSpecific ACE2 Expression in Cholangiocytes May Cause Liver Damage After 2019-nCoV Infection
Chai, X., Hu, L., Zhang, Y., Han, W., Lu, Z., Ke, A., Zhou, J., Shi, G., Fang, N., Fan, J., et al. (2020) · doi:10.1101/2020.02.03.931766 · Cited by 952 · cited 1×
“Recent studies have reported the expression of ACE2 in cholangiocytes, however, they do not reflect on the heterogeneity of the ACE2 population (23).”
BackgroundSharma, A., Seow, J. J. W., Dutertre, C.-A., Pai, R., Blériot, C., Mishra, A., Wong, R. M. M., Singh, G. S. N., Sudhagar, S., Khalilnezhad, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.040 · Cited by 677
Self-citationPotential hepatic stem cells reside in EpCAM+ cells of normal and injured mouse liver
Okabe, M., Tsukahara, Y., Tanaka, M., Suzuki, K., Saito, S., Kamiya, Y., Tsujimura, T., Nakamura, K., & Miyajima, A. (2009) · Development · doi:10.1242/dev.031369 · Cited by 287 · cited 1×
“Moreover, TROP2 expression has been associated with amplifying progenitor cells in the partial hepatectomy mouse model (24), indicating the important role of TROP2 cells in liver regeneration.”
Background
Research works printed but not linked: 19
- Chen, 2020, Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study, Lancet Lond Engl., 395, 507, 10.1016/S0140-6736(20)30211-7 · DOI · Paper page
- Hoffmann, 2020, SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor, Cell., 181, 271, 10.1016/j.cell.2020.02.052 · DOI · Paper page
- Chau, 2004, SARS-associated viral hepatitis caused by a novel coronavirus: report of three cases, Hepatology., 39, 302, 10.1002/hep.20111 · DOI · Paper page
- Alsaad, 2017, Histopathology of Middle East respiratory syndrome coronovirus (MERS-CoV) infection - clinicopathological and ultrastructural study, Histopathology., 72, 516, 10.1111/his.13379 · DOI · Paper page
- Zhang, 2020, Liver injury in COVID-19: management and challenges, Lancet Gastroenterol Hepatol., 5, 428, 10.1016/S2468-1253(20)30057-1 · DOI · Paper page
- Holshue, 2020, First case of 2019 novel coronavirus in the United States, New Engl J Medicine., 382, 929, 10.1056/NEJMoa2001191 · DOI · Paper page
- Huang, 2020, Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China, Lancet Lond Engl., 395, 497, 10.1016/S0140-6736(20)30183-5 · DOI · Paper page
- Kumar, 2020, Pattern of liver function and clinical profile in COVID-19: a cross-sectional study of 91 patients, Diabetes Metab Syndr Clin Res Rev., 14, 1951, 10.1016/j.dsx.2020.10.001 · DOI
- Schaefer, 2020, Interrelationship between coronavirus infection and liver disease, Clin Liver Dis., 15, 175, 10.1002/cld.967 · DOI
- Wang, 2020, Pattern of liver injury in adult patients with COVID-19: a retrospective analysis of 105 patients, Mil Med Res., 7, 28, 10.1186/s40779-020-00256-6 · DOI
- Mao, 2020, Implications of COVID-19 for patients with pre-existing digestive diseases, Lancet Gastroenterol Hepatol., 5, 425, 10.1016/S2468-1253(20)30076-5 · DOI · Paper page
- Gu, 2020, COVID-19: gastrointestinal manifestations and potential fecal-oral transmission, Gastroenterology., 158, 1518, 10.1053/j.gastro.2020.02.054 · DOI · Paper page
- Fondevila, 2021, Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points, J Hepatol., 74, 469, 10.1016/j.jhep.2020.09.027 · DOI
- Ma, 2020, Expression of SARS-CoV-2 receptor ACE2 and TMPRSS2 in human primary conjunctival and pterygium cell lines and in mouse cornea, Eye., 34, 1212, 10.1038/s41433-020-0939-4 · DOI · Paper page
- Seow, 2020, scRNA-seq reveals ACE2 and TMPRSS2 expression in TROP2+ liver progenitor cells: implications in COVID-19 associated liver dysfunction, Biorxiv, 10.1101/2020.03.23.002832 · DOI
- Cohn, 1993, Localization of the cystic fibrosis transmembrane conductance regulator in human bile duct epithelial cells, Gastroenterology., 105, 1857, 10.1016/0016-5085(93)91085-V · DOI · Paper page
- Crowell, 2019, Expansion of luminal progenitor cells in the aging mouse and human prostate, CelRep., 28, 1499, 10.1016/j.celrep.2019.07.007 · DOI
- Vallone, 2016, Trop2 marks transient gastric fetal epithelium and adult regenerating cells after epithelial damage, Dev Camb Engl., 143, 1452, 10.1242/dev.131490 · DOI
- Erben, 2017, A Novel ultrasensitive in situ hybridization approach to detect short sequences and splice variants with cellular resolution, Mol Neurobiol, 55, 6169, 10.1007/s12035-017-0834-6 · DOI
Cited by
ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19
Dong, M., Zhang, J., Ma, X., Tan, J., Chen, L., Liu, S., Xin, Y., & Zhuang, L. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110678 · Cited by 259
Iwasaki, M., Saito, J., Zhao, H., Sakamoto, A., Hirota, K., & Ma, D. (2021) · Inflammation · doi:10.1007/s10753-020-01337-3 · Cited by 229
On the whereabouts of SARS-CoV-2 in the human body: A systematic review
Trypsteen, W., Van Cleemput, J., Snippenberg, W. V., Gerlo, S., & Vandekerckhove, L. (2020) · PLOS Pathogens · doi:10.1371/journal.ppat.1009037 · Cited by 199
Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations
Thakur, V., Ratho, R. K., Kumar, P., Bhatia, S. K., Bora, I., Mohi, G. K., Saxena, S. K., Devi, M., Yadav, D., & Mehariya, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030446 · Cited by 147
Ashary, N., Bhide, A., Chakraborty, P., Colaco, S., Mishra, A., Chhabria, K., Jolly, M. K., & Modi, D. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00783 · Cited by 121
Self-citation
Metadata
- Authors
- Seow, J. J. W., Pai, R., Mishra, A., Shepherdson, E., Lim, T. K. H., Goh, B. K. P., Chan, J. K. Y., Chow, P. K. H., Ginhoux, F., DasGupta, R., & Sharma, A.
- Venue
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Published
- 2021-04-22
- Volume
- 8
- Pages
- 603374-603374
- ISSN
- 2296-858X (ISSN-L)
- OpenAlex
- W3154444530
- Cited by
- 50
- References
- 8
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- gold
- Funders
- National Health and Medical Research Council
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.